Filtered By:
Therapy: Corticosteroid Therapy
This page shows you your search results in order of date. This is page number 18.
Order by Relevance | Date
Total 2470 results found since Jan 2013.
Tocilizumab therapy for severely-ill COVID-19 pneumonia patients: a single-centre retrospective study
In conclusion: in low- and middle-income countries in the presence of limited therapeutic options, a timely intervention of TCZ alongside corticosteroids may be a suitable anti-inflammatory therapy for severely-ill hospitalized COVID-19 pneumonia patients to prevent mortality. However, patients must be closely monitored for secondary bacterial/fungal infections. Early diagnosis and management of secondary infection can reduce morbidity and mortality.PMID:36696245 | DOI:10.26402/jpp.2022.4.08
Source: J Physiol Pharmacol - January 25, 2023 Category: Drugs & Pharmacology Authors: S Iqtadar A Khan S U Mumtaz D A Pascual-Figal S Livingstone S Abaidullah Source Type: research
The baneful alliance of COVID-19 and mucormycosis: Histopathological concerns
CONCLUSION: Keeping a high index of suspicion for mucormycosis in COVID-19 by all medical fraternities of the health community in the existence of risk factors is the need of the hour for prompt diagnosis. Biopsy of antral necrotic tissue should be performed immediately after suspicion for histopathological study to confirm the diagnosis of mucormycosis and predict prognosis depending on the type of inflammation incited, fungal morphology, load, and necrosis.PMID:36656220 | DOI:10.4103/ijpm.ijpm_192_22
Source: Indian Journal of Pathology and Microbiology - January 19, 2023 Category: Pathology Authors: Anshu Singh Vijay Kumar Vikul Kumar Nidhi Verma Source Type: research
